Journal: Prescrire international 2014;22(142):249
PMID: 24298600
Extended follow-up of participants in the "DCCT" trial showed that, in type 1 diabetes, aiming for near-physiological blood glucose concentrations from the start of therapy reduces the risk of diabetic retinopathy, cardiovascular complications and renal impairment.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.